about
Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancersAssociation of BRM promoter polymorphisms and esophageal adenocarcinoma outcomePrimary esophageal and gastro-esophageal junction cancer xenograft models: clinicopathological features and engraftment.Development of Quality Metrics to Evaluate Pediatric Hematologic Oncology Care in the Outpatient Setting.A sticky situation: myocardial infarction in a young woman with immune thrombocytopenia on eltrombopag and a history of mediastinal radiation.Early adulthood body mass index, cumulative smoking, and esophageal adenocarcinoma survival.Hedgehog inhibition mediates radiation sensitivity in mouse xenograft models of human esophageal adenocarcinoma.
P50
Q28545204-9B469855-DCFA-4D28-AEC6-4CA20F60A672Q33709588-1732D982-6BE0-4517-BDFC-8AC834F11A81Q44944972-F2C35D7D-9513-454C-AD1B-8FE801DF9A90Q47729954-B2FE44C4-8781-40A6-BB77-FBCE5A0A4EBCQ48366304-7C39C3F8-FDFC-4021-8FDB-743D114B24E4Q54335625-247B9C50-C21A-42D3-8CE3-D833E0F8D81BQ55302141-2D82F3BF-92A9-4AC7-9836-88367FF126CC
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jennifer Teichman
@ast
Jennifer Teichman
@en
Jennifer Teichman
@es
Jennifer Teichman
@nl
Jennifer Teichman
@sl
type
label
Jennifer Teichman
@ast
Jennifer Teichman
@en
Jennifer Teichman
@es
Jennifer Teichman
@nl
Jennifer Teichman
@sl
prefLabel
Jennifer Teichman
@ast
Jennifer Teichman
@en
Jennifer Teichman
@es
Jennifer Teichman
@nl
Jennifer Teichman
@sl
P106
P21
P31
P496
0000-0002-7538-5772
P569
2000-01-01T00:00:00Z